CLINICAL_TRIALS
trial_result
· 2026-03-31
Clinical Trial Update: Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients [EARLY_Phase 1]
Summary
A Phase 1 safety and efficacy trial of the gene therapy ZM-01 for X-linked retinoschisis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhongmou Therapeutics | Conditions: X-linked Retinoschisis | EARLY_Phase 1 | Status: COMPLETED